Skip to content

Clinical trials

Phase 2/3 trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Country / region: Germany Clear all

521 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20006
20016
200211
200310
200421
200519
200626
200718
200816
200929
201023
201122
201220
201316
201415
201525
201616
201715
201823
201921
202026
202124
202225
202324
202419
202524
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed265
Terminated93
Recruiting63
Unknown status42
Active, not recruiting38
Withdrawn10
Enrolling by invitation7
Not yet recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Charite University, Berlin, Germany22
Novartis Pharmaceuticals13
Bristol-Myers Squibb12
Pfizer12
Janssen Research & Development, LLC10
University Hospital Tuebingen10
Boehringer Ingelheim9
Hoffmann-La Roche9
University Medicine Greifswald8
AbbVie7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-1914
Carcinoma, Non-Small-Cell Lung14
Alzheimer Disease13
Colitis, Ulcerative13
Breast Neoplasms10
Neoplasm Metastasis10
Neoplasms10
Heart Failure9
Lung Neoplasms9
Recurrence9

Trials

Showing 51 to 75 of 521. Each trial links to its page on Pharma Observatory.

421 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.